David McDermott
NIH Rank #12339
- Program Leader
- R01 Holder
- Early Career
- Diverse Portfolio
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 9223203Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
NIH Funding · FY2024
Linked Award Amount
$1.2M
Full award amounts, FY2024
Award Records
3
Records listing this PI
Award-Linked Rank
#12,339
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2024 award records by amount
NIH award records listing David McDermott as a PI. Multi-PI records show the full award amount for context.
- 2U01CA236489-05A1U01Developing a Translation Pipeline for VHL Mutant Malignancies$669.2Kaward amount
- 5R01CA258442-03R01Clinical characterization of Kidney Injury Molecule-1 (KIM-1) as a Biomarker in Renal Cell Carcinoma$374.2Kaward amount
- $138.6Kaward amount
Award organization
Organizations that administered FY2024 awards listing David McDermott as a PI.
FY2024 award administered by Beth Israel Deaconess Medical Center (MA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardBeth Israel Deaconess Medical Center
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2025$2M Cumulative Funding
- 2025R01 Grant Holder
- 2025Program/Center Grant Leader
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as David McDermott.